Abstract:Genomic variants causing abnormal splicing play an important role in genetic disorders and cancer development. Among them, variants that cause formations of novel splice-sites (splice-site creating variants, SSCVs) are particularly difficult to identify and often overlooked in genomic studies. Additionally, these SSCVs, especially those found in deep intronic regions, are frequently considered promising candidates for treatment with splice-switching antisense oligonucleotides (ASOs), offering therapeutic potential for rare disease patients. To leverage massive transcriptome sequence data such as those available from the Sequence Read Archive, we developed a novel framework to screen for SSCVs solely using transcriptome data. We have applied it to 322,072 publicly available transcriptomes and identified 30,130 SSCVs. Utilizing this extensive collection of SSCVs, we have revealed the characteristics of Alu exonization via SSCVs, especially the hotspots of SSCVs within Alu sequences and their evolutionary relationships. Many of the SSCVs affecting disease-causing variants were predicted to generate premature termination codons and are degraded by nonsense-mediated decay. On the other hand, several genes, such as and showed characteristic SSCV profiles indicative of heterogeneous mutational functions beyond simple loss-of-function. Finally, we discovered novel gain-of-function SSCVs in the deep intronic region of the gene and demonstrated that their activation can be suppressed using splice-switching ASOs. Collectively, we provide a systematic approach for automatically acquiring a registry of SSCVs, which can be used for elucidating novel biological mechanisms for splicing and genetic variation, and become a valuable resource for pinpointing critical targets in drug discovery. Catalogs of SSCVs identified in this study are accessible on SSCV DB ( ).

Mapping RNA splicing variations in clinically accessible and nonaccessible tissues to facilitate Mendelian disease diagnosis using RNA-seq

Identification of diagnostic candidates in Mendelian disorders using an RNA sequencing-centric approach

Machine learning-optimized targeted detection of alternative splicing

RNA Splicing Analysis: from in Vitro Testing to Single-Cell Imaging

Clinical validation of RNA sequencing for Mendelian disorder diagnostics

ParSE-seq: a calibrated multiplexed assay to facilitate the clinical classification of putative splice-altering variants

Nanopore Deep Sequencing as a Tool to Characterize and Quantify Aberrant Splicing Caused by Variants in Inherited Retinal Dystrophy Genes

Improved methods for RNAseq-based alternative splicing analysis

Integrated Analysis of a Compendium of RNA-Seq Datasets for Splicing Factors.

Identification of synonymous pathogenic variants in monogenic disorders by integrating exome with transcriptome sequencing

Short amplicon reverse transcription-polymerase chain reaction detects aberrant splicing in genes with low expression in blood missed by ribonucleic acid sequencing analysis for clinical diagnosis

The human splicing code reveals new insights into the genetic determinants of disease

Comparison of in silico strategies to prioritize rare genomic variants impacting RNA splicing for the diagnosis of genomic disorders

RNA variant assessment using transactivation and transdifferentiation

Systematically developing a registry of splice-site creating variants utilizing massive publicly available transcriptome sequence data

Splicedisease Database: Linking Rna Splicing and Disease

Computational Identification of Tissue-Specific Splicing Regulatory Elements in Human Genes from RNA-Seq Data

Detection of Splice Junctions from Paired-End RNA-seq Data by SpliceMap

Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease

Interrogations of single-cell RNA splicing landscapes with SCASL define new cell identities with physiological relevance

Systematic evaluation of the two main blood-based RNA-seq approaches for Mendelian disease diagnosis